Enzo Biochem (NYSE:ENZ) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of Enzo Biochem (NYSE:ENZ) in a research report released on Friday. The brokerage issued a hold rating on the medical research company’s stock.

Enzo Biochem Price Performance

Shares of Enzo Biochem stock opened at $1.04 on Friday. Enzo Biochem has a twelve month low of $0.99 and a twelve month high of $1.50. The company’s fifty day moving average is $1.13 and its 200 day moving average is $1.12.

Enzo Biochem Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 2nd. Investors of record on Friday, November 15th will be paid a $0.10 dividend. The ex-dividend date of this dividend is Friday, November 15th. This represents a $0.40 annualized dividend and a dividend yield of 38.46%.

Hedge Funds Weigh In On Enzo Biochem

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Geode Capital Management LLC lifted its holdings in Enzo Biochem by 3.3% in the third quarter. Geode Capital Management LLC now owns 368,646 shares of the medical research company’s stock valued at $413,000 after buying an additional 11,742 shares during the period. XTX Topco Ltd lifted its holdings in Enzo Biochem by 94.5% in the second quarter. XTX Topco Ltd now owns 28,262 shares of the medical research company’s stock valued at $31,000 after buying an additional 13,735 shares during the period. Renaissance Technologies LLC lifted its holdings in Enzo Biochem by 2.6% in the second quarter. Renaissance Technologies LLC now owns 2,499,546 shares of the medical research company’s stock valued at $2,725,000 after buying an additional 64,417 shares during the period. Finally, BBR Partners LLC acquired a new position in Enzo Biochem in the third quarter valued at $112,000. Institutional investors and hedge funds own 36.90% of the company’s stock.

About Enzo Biochem

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.